Perrigo | PRGO - Ebit

Stock Price
9.30
Daily Change
-0.12 -1.27%
Monthly
-36.30%
Yearly
-66.70%
Q1 Forecast
9.80

Perrigo reported $84.4M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
Abbott USD 2.54B 358M Dec/2025
Bayer EUR 1.11B 1.51B Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Coherus Biosciences USD -45.43M 3.19M Mar/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Dr.Reddys Laboratories INR 13.94B 1.79B Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
J&J USD 5.11B 2.3B Dec/2025
Merck USD 6.24B 1.32B Dec/2025
Nestle CHF 7.14B 689M Jun/2025
Pacira USD 3.19M 9.96M Dec/2025
Perrigo USD 84.4M 9M Dec/2025
Pfizer USD 4.65B 71M Dec/2025
Phibro Animal Health USD 26M 5.54M Sep/2024
Prestige Brands USD 82.49M 2.82M Dec/2025
Reckitt Benckiser GBP 1.79B 109M Dec/2024
Sanofi EUR 1.7B 2.17B Dec/2025
Supernus Pharmaceuticals USD 13.82M 74.01M Dec/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025
Xeris Pharmaceuticals USD 7.89M 2.46M Sep/2025
Zoetis USD 835M 140M Dec/2025